All News Nuformix plc

Equities

Delayed London S.E. Other stock markets 03:55:19 02/07/2024 pm IST			5-day change	1st Jan Change
0.15 ^GBX	-14.29%		-10.45%	-53.85%

18/06	Nuformix shares fall despite interim loss narrowing	AN
18/06	Nuformix plc Reports Earnings Results for the Half Year Ended March 31, 2024	CI

Nuformix shares fall despite interim loss narrowing	18/06	AN
Nuformix plc Reports Earnings Results for the Half Year Ended March 31, 2024	18/06	CI
Nuformix Secures New EU, US Patents for Development Programs	17/06	MT
Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment	17/06	AN
Nuformix plc Announces Patent Update	17/06	CI
Nuformix announces subscription to raise GBP150,000	01/03	AN
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	15/01	CI
Nuformix narrows annual loss as develops drug assets	03/01	AN
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	03/01	MT
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	03/01	CI
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23/23/23	AN
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23/23/23	MT
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23/23/23	CI
Nuformix to fund its unlicensed programs with NXP001 windfall	05/23/05	AQ
Nuformix Updates Oxilio Agreement for NXP001	18/23/18	MT
Nuformix to receive milestone payments from Oxilio pact	18/23/18	AN
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	18/23/18	CI
Nuformix loss narrows; near-term goal to focus on NXP002 asset	22/23/22	AN
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	22/23/22	MT
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	22/23/22	MT

No results for this search